A

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Senior Manager - Preclinical Study Management

Clinical Research OperationsPosted on Nov 10
Full-timeCambridge, MA, USA$144.8k - $196kHybrid

About the Job

Requirements

  • A bachelor's degree in biology/toxicology or a related field and at least 8 years of relevant experience in the biotechnology/pharmaceutical industry or a contract research organization.
  • Knowledge of global regulatory guidelines, including ICH, GLP, and OECD.
  • Previous Study Directorship or Study Coordination at a contract research organization is highly desired.
  • Strong attention to detail and the ability to critically evaluate study-related documentation and correspondence.
  • Previous experience conducting laboratory animal research studies is a plus.
  • Working knowledge of invoicing, accounting, and contract management is preferred.
  • Demonstrated organizational and multitasking skills and effective time/program management.
  • Proficiency in Smartsheet.
  • Ability to navigate a fast-paced, highly networked, program-team-driven environment with frequent course corrections and changing deliverables and timelines.

Responsibilities

  • Oversee externally contracted in vivo and in vitro studies supporting research and early development programs, collaborating with internal research and development teams to design, manage, track, and report preclinical studies conducted at external contract research organizations.
  • Work with study teams to develop or obtain accurate study designs, assess external capabilities, prepare requests for quotations for qualified laboratories, evaluate and compare proposals, cost estimates, and timelines, and ensure compliance with the approved investment plan.
  • Support funding applications and award studies to qualified laboratories, securing appropriate resources and timelines.
  • Support protocol development, monitor study conduct, ensure accurate and timely reporting of study results, and archive study materials and data within company systems.
  • Maintain current and long-range budget projections, including financial forecasting for up to five years.
  • Generate and submit concept sheets to contract research organizations and obtain competitive bids and timelines; negotiate as appropriate.
  • Work with Toxicology, DMPK, Bioanalysis, Biology, Pathology, CMC, Program Management, Accounting, Legal, Procurement, Supply Chain, and Sample Management to facilitate planning, development, tracking, and study timelines for outsourced nonclinical studies.
  • Generate statements of work and review and process contract research organization contracts.
  • Assist Research and Early Development personnel in preparing for contract research organization studies, including protocol development, animal orders, test article projections, and shipments.
  • Assist investigators with preparing, reviewing, and circulating study documents, including protocols and amendments.
  • Maintain complete, organized, and current study files, including study schedules, contracts, protocols, applicable documents, and correspondence.
  • Work with the technical writing group and other company personnel to manage and track internal report and sub-report timelines and status.
  • Provide administrative support for contracted nonclinical studies.
  • Work with CMC and Supply Chain to manage test article supplies and orders.
  • Work with contract research organizations and Analytical Chemistry to assure GLP-compliant test article characterization and stability and retests.
  • Conduct contract research organization site visits for study monitoring at key study milestones.
  • Participate in regular teleconferences with contract research organizations, including pre-study meetings, bi-weekly/monthly program meetings, operational meetings, and pre-reporting tox/pathology meetings.
  • Work with Business Planning and Program Management and Accounting/Finance to assist with accurate investment plan forecasting, award contracts, and review and process invoices for payment.
  • Interact cross-functionally within Research and Early Development, with project teams, and across other drug development expertise areas.
  • Manage outsourcing of GLP and non-GLP preclinical studies for regulatory submissions, including pharmacokinetic, toxicology, and biodistribution studies.
  • Work within established contract research organization agreement terms to support preclinical development programs.
  • Act as the primary contact for and provide oversight to contract research organization partners to ensure consistent practices across vendors, groups, and sites; communicate and troubleshoot issues; and track/forecast activities.
  • Participate in selecting contract research organizations, including qualification/scientific assessments, and track vendor performance.
  • Help manage the master schedule in Smartsheet for internal and external preclinical studies using an in-house preclinical study database.
  • Help facilitate study coordination meetings between groups to align resources and workloads.
  • Assist with process improvement initiatives.
  • Ensure compliance with global preclinical study regulatory guidelines.
  • Assist with scientific site qualifications.
  • Take on other projects as needed.

Desired Qualifications

  • PhD in a biology/toxicology-related field.

About the Company

Alnylam Pharmaceuticals

Develops RNAi-based therapies for genetic diseases

Alnylam Pharmaceuticals develops RNA interference (RNAi) therapeutics to silence disease-causing genes, aiming to treat rare genetic disorders. Its products work by using RNA molecules that block gene expression, reducing the impact of specific genetic diseases. The company differentiates itself by concentrating on RNAi-based drugs for rare diseases and by building a pipeline through large clinical programs and strategic partnerships, such as commercialization deals in the Gulf States and collaborations with investors. Revenue comes from approved drug sales, licensing agreements, strategic collaborations, and related services like genetic testing and counseling. The company’s goal is to advance and commercialize RNAi therapies to improve outcomes for patients with genetic disorders, expanding its portfolio through partnerships and investments.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Cambridge, MA
Founded
2002

Recently Posted Jobs

Explore more opportunities at Alnylam Pharmaceuticals

See more jobs